Radiation Oncology/Therapy: Page 14

PET/MRI scanner damaged by copper wire theft

By AuntMinnieEurope.com staff writers

A 4-million-pound (4.74 million euros) PET/MRI scanner at Newcastle University's Centre for In-Vivo Imaging in the U.K. has been damaged beyond repair due to the theft of copper wire from a nearby electricity substation, according to a BBC report.

December 22, 2021

U.K. releases guidance on molecular radiotherapy

By AuntMinnieEurope.com staff writers

Changes in the U.K. healthcare systems will be required for patients to fully benefit from recent advances in molecular radiotherapy, according to U.K. medical societies.

December 12, 2021

Dr. Bruce Haffty named president of RSNA board

By AuntMinnieEurope.com staff writers

The RSNA named prominent radiation oncologist Dr. Bruce Haffty as the new president of its board on 1 December at its annual meeting.

December 5, 2021

ITM, Navigo collaborate on radioisotope

By AuntMinnieEurope.com staff writers

German radiopharmaceutical firm ITM Isotope Technologies Munich and Navigo Proteins are teaming up to develop a fibroblast activation protein-targeted radiopharmaceutical program for the treatment of solid tumors.

December 2, 2021

Kheiron appoints London academic as head of machine learning

By AuntMinnieEurope.com staff writers

U.K. artificial intelligence software developer Kheiron Medical Technologies has appointed Imperial College London researcher Ben Glocker, PhD, as head of machine-learning research.

November 30, 2021

The show goes on: ESR vows to push ahead with in-person congress

By Philip Ward

The European Society of Radiology (ESR) is pressing on with plans to stage ECR 2022 as a face-to-face meeting in Vienna, despite the national lockdown that has now begun in Austria.

November 22, 2021

Monrol and MTTI ink Lu-177 supply deal

By AuntMinnieEurope.com staff writers

EczacıbaŞı-Monrol Nuclear Products has signed an agreement to supply Molecular Targeting Technologies (MTTI) with no-carrier-added lutetium-177 (Lu-177).

November 18, 2021

Clarity hits milestone in study of radiopharmaceutical

By AuntMinnieEurope.com staff writers

Clarity Pharmaceuticals, the Australian-based radiopharmaceutical developer, has completed patient recruitment in the dosimetry phase of a study of its theranostic agent with copper-based radioisotopes for treating metastatic castration-resistant prostate cancer.

November 14, 2021

ANSTO to partner with Cyclotek on theranostics facility

By AuntMinnieEurope.com staff writers

The Australian Nuclear Science and Technology Organisation (ANSTO) is entering into a joint venture with Cyclotek to build a new theranostics facility in Melbourne.

November 9, 2021

Goh provides glimpse into future world of hybrid imaging

By Frances Rylands-Monk

How can the clinical potential of PET/MRI be unlocked? What challenges lie ahead? Cancer imaging expert Prof. Vicky Goh took out her crystal ball and provided some insight into the future role of PET/MRI and how both modalities can be integrated effectively. She also touched on PET/CT.

November 8, 2021

Details emerge of plan to increase imaging capacity in U.K.

By Erik L. Ridley

The U.K. government has pledged to allocate 2.3 billion pounds in its new budget to an initiative aimed at increasing diagnostic services capacity in the National Health Service and clearing the backlog of scans.

October 26, 2021

Best Theratronics lands multiple cyclotron orders

By AuntMinnieEurope.com staff writers

TeamBest Global company Best Theratronics has garnered $30 million (26 million euros) worth of international orders for new cyclotron systems and upgrades.

October 25, 2021

Previous Page

Page 14 of 126

Next Page